Skin infection
MONDO:0021201An inflammatory process affecting the skin, caused by bacteria, viruses, parasites, or fungi. Examples of bacterial infection include carbuncles, furuncles, impetigo, erysipelas, and abscesses. Examples of viral infection include shingles, warts, molluscum contagiosum, and pityriasis rosea. Examples of parasitic infection include scabies and lice. Examples of fungal infection include athlete's foot, yeast infection, and ringworm.
Also known as: skin infection
153 clinical trials for this condition and its sub-types, 12 tagged with Skin infection itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Skin infection
-
Tinea infection 1 trial · 116 incl. sub-types
9 sub-types
- Dermatophytosis 6 trials · 82 incl. sub-types Sub-types →
- Cutaneous candidiasis 0 trials · 25 incl. sub-types Sub-types →
- Fungal infection of the toenail 4 trials
- Otomycosis 4 trials Sub-types →
- Pityriasis versicolor 4 trials
- Conidiobolomycosis 0 trials
- Deep seated dermatophytosis 0 trials
- Eumycotic mycetoma 0 trials
- Tinea favosa 0 trials
-
Scabies 12 trials
1 sub-type
- Norwegian scabies 0 trials
-
Demodex folliculitis 5 trials
-
Impetigo 5 trials
2 sub-types
- Ecthyma 0 trials
- Impetigo herpetiformis 0 trials
-
Infection by Trypanosoma gambiense 3 trials
-
Erysipelas 1 trial
-
Pthirus pubis infestation 0 trials
-
Cercarial dermatitis 0 trials
-
Cutaneous diphtheria 0 trials
-
Furunculosis 0 trials
-
Gonococcal keratitis 0 trials
-
Herpes simplex dermatitis 0 trials
-
Herpes zoster dermatitis 0 trials
1 sub-type
-
Sycosis barbae 0 trials
Most studied deeper sub-types
-
Which antibiotic wins for skin infections? study pits doxycycline against TMP-SMX
Disease control CompletedThis study compared two common antibiotics, doxycycline and TMP-SMX, for treating uncomplicated skin infections like boils and cellulitis. 269 people aged 9 to 85 took one of the drugs for 7 days. Researchers checked if the infection cleared up early, at the end of treatment, and…
Phase 2 • Sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC
-
One shot wonder? new antibiotic trial for Kids' skin infections
Disease control CompletedThis study tested a single dose of the antibiotic oritavancin in 118 children aged 3 months to 12 years with acute bacterial skin infections. The goal was to see if it is safe and tolerable. Researchers also looked at how the drug works in the body and whether it cures the infect…
Phase 2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Honey heals: sweet solution may beat standard ointment for hearing aid skin woes
Prevention CompletedThis study tested whether applying medical-grade honey after bone-anchored hearing aid surgery could prevent skin breakdown better than the usual bacitracin ointment. Seventeen adults were randomly assigned to receive either honey or bacitracin for two weeks after surgery. Resear…
Phase 4 • Sponsor: Henry Ford Health System • Aim: Prevention
Last updated Jun 27, 2026 08:09 UTC
-
Labour antibiotic may shield newborns from infections
Prevention CompletedThis study tested whether giving mothers a single 2-gram dose of the antibiotic azithromycin during labour could reduce the risk of skin and soft tissue infections in their babies during the first three months of life. Over 2,000 pregnant women in Fiji took part, receiving either…
Phase 3 • Sponsor: Murdoch Childrens Research Institute • Aim: Prevention
Last updated Jun 26, 2026 14:38 UTC
-
Home hospital care for infections: when does it fail?
Knowledge-focused CompletedThis study looks back at medical records of adults who were sent home from the emergency department to receive hospital-level care for common infections like pneumonia, urinary tract infections, or skin infections. The goal is to understand why some of these patients end up needi…
Sponsor: Chimei Medical Center • Aim: Knowledge-focused
Last updated Jul 24, 2026 00:00 UTC